News
CEP for Baclofen available
02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of Medicines (EDQM) for Baclofen
Polpharma – the most innovative company in Poland
20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute of Economic Sciences of the Polish Academy of Sciences.
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex
08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the development of APIs and advanced intermediates.
Co-operation between Polpharma and RPG Life Sciences
05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and in the management of the supply chain of selected high value APIs like clopidogrel bisulphate.
Latest API developments
30-09-2010
The Fine Chemicals Business Unit has successfully completed the development of two new APIs – Darifenacin hydrobromide and Rosuvastatin calcium
Latest news
CEP for Baclofen available
Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...
Polpharma – the most innovative company in Poland
Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex
Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...
Co-operation between Polpharma and RPG Life Sciences
Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...